Northstar Medical Radiosotopes

IN THE PRESS

BioMidwest

NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)

March 1, 2023

·

6 min read

BioMidwest

NorthStar Medical Radioisotopes Sets New Industry Precedent in Advancing Non-uranium based Commercial Production of Molybdenum-99 (Mo-99)

January 11, 2023

·

5 min read

BioMidwest

NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates

January 4, 2023

·

7 min read

BioMidwest

NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit

November 15, 2022

·

6 min read

Business

Radiopharm Theranostics Signs Agreement With NorthStar Medical Radioisotopes for the Supply of Non-Carrier Added (n.c.a.) Actinium-225

October 26, 2022

·

4 min read

BioMidwest

Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility

October 11, 2022

·

4 min read

Business

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes

September 20, 2022

·

5 min read

Business

NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology, Inc. for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)

August 23, 2022

·

4 min read

Business

NorthStar Medical Radioisotopes Announces Supply Agreement with Clovis Oncology for Therapeutic Radioisotope Actinium-225 (Ac-225)

July 19, 2022

·

4 min read

Business

Veritas Medical Solutions and NorthStar Medical Radioisotopes Partnered to Construct a Radiation Shielded Vault

June 27, 2022

·

2 min read

JOBS